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Abstract Hepatopoietin (HPO)/ALR (augmenter of liver re-
generation), as a versatile hepatotrophic growth factor and a
cellular thiol oxidase, is involved in a wide variety of basic
processes of various tissues, especially in liver and testis.
Here, we studied the regulation of HPO gene expression. By
sequential deletion of the HPO 5P-£anking region, the minimal
promoter of the HPO gene was shown to span positions 322 to
+42 relative to the transcriptional start point. Further trans-
fection assay and mutation analysis showed that the core pro-
moter contains a functional initiator. Interestingly, three tandem
repeats of a CTGGAGGC element, surrounding the transcrip-
tion start site and bound by speci¢c nuclear factors, were found
to be pivotal for the promoter activity. This initiator £anking
element functions in an initiator-dependent fashion and is
present in many initiator-containing genes. Taken together,
our ¢ndings revealed that the initiator-like element and its
£anking repeat sequence comprise a core promoter and drive
the transcriptional initiation of the HPO gene in a combinato-
rial manner. The HPO gene promoter might represent a novel
architecture for core promoters.
1 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Hepatopoietin (HPO) belongs to the new HPO/ALR (aug-
menter of liver regeneration)/Erv1p protein family, members
of which are found in eukaryotes from yeast to man and even
in some double-stranded DNA viruses [1,2]. Family members
share domains of approximate 100 amino acids that are ca.
30% identical and contain a CXXC motif, a feature of thio-
redoxin-like proteins [3].
Mammalian HPO/ALR was originally identi¢ed as a hep-
atotrophic growth factor that can speci¢cally stimulate liver
regeneration after partial hepatectomy in vivo and prolifera-
tion of cultured primary hepatocytes in vitro [1,4]. Later, it
was found that the receptor of HPO exists on the membrane
of primary hepatocytes and hepatoma cell lines [5], and that
HPO might act as an autocrine growth factor to stimulate
autonomous proliferation of hepatoma cells [6]. Further in-
vestigations showed that extracellular HPO stimulates pro-
liferation of hepatoma cells via the signaling of mitogen-
activated protein kinase through epidermal growth factor
receptor [7], and that intracrine HPO interacts with JAB1 to
modulate the transcriptional activity of AP1 [8]. In addition, it
was demonstrated that HPO/ALR reduces the lytic activity of
liver-resident natural killer cells and the expression level of
mitochondrial transcription factor A by down-regulating in-
terferon-Q [9,10]. Intriguingly, recent investigations have re-
vealed that ERV1p/ALR is a cellular FAD-linked sulfhydryl
oxidase that participates in a cytoplasmic pathway of disul¢de
bond formation [11^14]. Taken together, these characteristics
indicate that HPO and its analogs take part in a wide variety
of basic processes that are operational in various cells and
tissues.
Since HPO participates in so many fundamental processes,
the regulation mechanism of its gene expression might display
signi¢cant impact on those fundamental processes. Up to
now, however, there have been no reports on such a mecha-
nism in this promising family. In the present study, we tried to
elucidate the molecular mechanisms that direct the expression
of the HPO gene. The 5P-£anking region of the human HPO
gene was cloned and its promoter activity was characterized.
The data showed that a functional initiator (Inr)-like element
and its £anking repeat elements together comprise a core pro-
moter to direct the transcriptional initiation of the HPO gene.
In addition, the signi¢cance of HPO’s initiator with its £ank-
ing elements as potentially a novel type of general transcrip-
tional apparatus is further discussed.
2. Materials and methods
2.1. Isolation of the HPO promoter region from the human genome
A 1529-bp fragment of the HPO promoter region was isolated from
human placenta genomic DNA by polymerase chain reaction (PCR)
with sense primer 5P-GAAATCCACTCCCCATATGATAGCCAGC-
3P and antisense primer 5P-CCACGTCTTGAAGTCGACGCAGGC-
CCGG-3P. The ampli¢ed fragment was ligated into pGEM-T vector
(Promega) to generate pGEM-T-HPO. This genomic DNA was then
con¢rmed by sequencing and used as template of PCR in subsequent
plasmid construction.
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2.2. Plasmid constructions
A series of 5P-truncated constructs were created by PCR with com-
binations of the common antisense primer 5P-GCGCCTGGGCTGG-
CGTCGAG-3P and di¡erent sense primers. XhoI and HindIII recog-
nition sequences were incorporated into the sense and antisense
primers, respectively, and PCR products were subcloned into the re-
porter vector pGL3-Basic (Promega) at the corresponding sites. In
this way we produced the 5P-truncated plasmids pGL3-HPO(31222/
+205), pGL3-HPO(31000/+205), pGL3-HPO(3793/+205), pGL3-
HPO(3608/+205), pGL3-HPO(3416/+205), pGL3-HPO(3236/+205),
pGL3-HPO(354/+205), and pGL3-HPO(+110/+205). The numbers in
parentheses indicate the boundaries of the inserts relative to a putative
transcription start site, which is the purine A within the Inr-like ele-
ment as described in Section 3.
2.3. Mutagenesis
Oligonucleotide-directed mutagenesis with the overlap extension
PCR ampli¢cation method [15] was used to mutate the major tran-
scription start site and the three £anking CTGGAGGC repeats in the
context of pGL3-HPO(354/+205) by transversion at 321/318
(TGGC to GTTA); 39/36 (TGGC to GTTA); 31/32 (TC to
AG); +2/+3 (TC to GA); +4/+7 (TGGC to GTTA) and a transition
at +1 (A residue to G). The mutated segments of pGL3-HPO(354/
+205) furnished with XhoI and HindIII sites were directly subcloned
into pGL3-Basic as described above. All of the mutants were veri¢ed
by sequencing.
2.4. Cell culture and transient transfection
Cells used in this experiment were maintained as monolayer cul-
tures and grown in Dulbecco’s modi¢ed Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum in a humidi¢ed 5% CO2
incubator at 37‡C. For transient transfection, cells were plated in
24-well tissue culture plates at a density of 2U105 cells per well in
1.2 ml of DMEM (Life Technologies). After a 24-h attachment period
(50^60% con£uence of cells), transfections were performed with Lipo-
fectAmine PLUS reagent (Life Technologies) following the manufac-
turer’s instruction. Brie£y, 0.4 Wg of each construct of HPO promoter,
0.04 Wg of pRL-TK and 2 Wl of PLUS reagent and 2 Wl of Lipofect-
Amine in a total amount of 250 Wl serum-free DMEM were mixed
and added to cells. After 6 h incubation, the medium containing the
LipofectAmine^DNA complex was removed and replaced by DMEM
containing 10% fetal bovine serum. Cells were then cultured further
for 48 h and harvested in passive lysis bu¡er (Promega). Luciferase
assays were conducted with the Dual Luciferase Assay system (Prom-
ega) according to the manufacturer’s recommendations with modi¢-
cation for 10 Wl of cell lysate in 50 Wl of ¢re£y/Renilla luciferase assay
reagent. To normalize the transfection e⁄ciency, the ¢re£y luciferase
activity was divided by the Renilla luciferase activity from the internal
control pRL-TK. All transfection and reporter assays were performed
independently at least three times, each in duplicate or triplicate
as shown in the ¢gure legends. The results are presented as means
US.D.
2.5. Preparation of nuclear extract
Nuclear extracts were prepared from HepG2 cells as described by
Therrien and Drouin [16]. Protein concentration was determined ac-
cording to Bradford [17]. The extracts were frozen in aliquots and
stored at 370‡C. The HeLa nuclear extract was purchased from
Promega.
2.6. Electrophoretic mobility shift assay (EMSA)
Oligonucleotides were annealed in equimolar amounts and end-la-
beled with 32P in the presence of [Q-32P]ATP and T4 polynucleotide
kinase. The oligonucleotides used in these assays were as follows (the
mutated nucleotides are in lower case): wild-type Inr, 5P-AGGCTC-
ATCTGGAGGCCGA-3P ; mut 32/+2, 5P-AGGCgacgCTGGAGGC-
CGA-3P ; mut +4/+7, 5P-AGGCTCATCgttcGGCCGA-3P ; wild-type
R1, 5P-TCTGGCCTGGAGGCTGACC-3P ; mut R1, 5P-TCTGGCC-
gttcGGCTGACC-3P. The consensus oligonucleotides for AP1 (5P-C-
GCTTGATGAGTCAGCCGGAA-3P) and Sp1 (5P-ATTCGATCGG-
GGCGGGGCGAGC-3P) were purchased from Promega. For each
binding reaction, a total of 35 fmol probe labeled with [Q-32P]ATP
was combined with 5 Wg nuclear proteins in 10 mM Tris^HCl (pH
7.5), 50 mM NaCl, 0.5 mM dithiothreitol, 0.5 mM EDTA, 1 mM
MgCl2, 0.05 mg/ml poly(dI-dC) and 4% glycerol (v/v), in a total
volume of 10 Wl. Reaction mixtures were incubated for 20 min at
room temperature and resolved on a non-denaturing (4%, w/v) acryl-
amide gel (29:1, w/w) in 0.5UTBE. For competition assay, a 100^
1000-fold molar excess of various unlabeled competitor DNAs was
added to the reaction mixture prior to the addition of the labeled
probe. The gel was then exposed to X-ray ¢lm at 370‡C with an
intensifying screen.
3. Results
3.1. Promoter activity of HPO 5P-£anking region
To identify important regions regulating HPO gene tran-
scription, we generated a series of sequential 5P-deletions of
the HPO 1222-bp 5P-£anking region contiguous to the pro-
moter and 205-bp 5P-untranslated region, fused to a luciferase
reporter gene (Fig. 1A). These constructs were transiently
transfected into HepG2 cells, 293 cells and HeLa cells, and
the luciferase activity was determined. The data showed that
the promoter region of HPO has transcriptional activity in all
tested cell lines (Fig. 1B). Furthermore, the e¡ect of sequential
5P-deletion on transcriptional activity was similar among the
three transfected cell lines for all constructs except for pGL3-
HPO(3608/+205) (Fig. 1B). This indicates that the 5P-£anking
region of HPO gene might have a similar regulatory pattern
in cell lines of various origins. For the pGL3-HPO(3608/
+205) construct, the promoter activity was decreased in
HepG2 cells and HeLa cells, whereas it was increased in 293
cells (Fig. 1B). Among the various constructs, deletion from
31222 to 31000 reduced the luciferase activity in all three
cells. This indicates that positive regulatory elements might
be present in the region from 31000 to 31222. Deletion of
fragments from 31000 to 3608 has less in£uence on tran-
scriptional activity. However, deletion downstream of 3416
resulted in a 1.5^4-fold decrease, whereas further deletion to
3236 caused a 5^12-fold increase in luciferase activity (Fig.
1B). These results indicate that positive regulatory elements
may exist in the region from 3416 to 3608 and negative
regulatory elements may lie in the region between 3416 and
3236. In HepG2 and HeLa cells, the highest promoter activ-
ity was observed in the pGL3-HPO(354/+205) construct.
However, pGL3-HPO(+110/+205), formed by the removal
of 164 bp from the 5P-end of pGL3-HPO(354/+205), was
devoid of promoter activity (Fig. 1B). These data suggest
that the minimal promoter of HPO lies somewhere between
354 and +110.
3.2. A minimal core promoter is present in the region from 322
to +42
The results above showed that the minimal fragment of
354 to +205 alone has high promoter activity, which indicates
that a core promoter may be present in this region and may
initiate transcription of the gene. To more accurately dissect
the position of the core promoter, we performed reporter
assays of 5P- and 3P-truncated forms starting from pGL3-
HPO(354/+205). Luciferase activity was still high when the
fragment of 354 to +205 was truncated to 322 and then was
lost upon further truncation to +27 from the 5P-end (Fig. 1C).
The results suggest that the minimal core promoter exists in
the region between 322 and +27. The deduction was con-
¢rmed by truncation from the 3P-end. The promoter activity
of pGL3-HPO(354/+42) was still 75.8% of that seen with
pGL3-HPO(354/+205) (Fig. 1C). Sequence analysis of the
region revealed that it lacks a canonical TATA box, but has
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a sequence CTCATCTGGAGGC with homology to the Inr
sequence element CTCATTCTGGAGAC in the mouse termi-
nal deoxynucleotidyltransferase (TdT) gene [18]. Intriguingly,
in addition to one CTGGAGGC sequence within the Inr-like
element, two other tandem repeats lie upstream of the Inr-like
element (Fig. 1D), suggesting that the Inr-like element and its
£anking repeats might be involved in transcriptional initiation
of the HPO gene.
Fig. 1. Transcriptional activities of the human HPO promoter. A: Schematic diagram of the cloned HPO promoter region, showing the 5P-
£anking region of HPO immediately downstream of an Alu repeat (hatched bar) to exon I (¢lled bar). A total of 1427 bp was cloned by PCR
according to GenBank1 sequence AC005606. The purine A within Inr-like element CTCATCTGG was designated +1. B: The 5P-truncated
HPO promoter regions shown on the left were inserted into pGL3-Basic. The reporter constructs were transfected to HepG2 (grey ¢lled bar),
293 (dark ¢lled bar) and HeLa (open bar) cells. Fire£y luciferase activities were normalized to the Renilla luciferase activity of pRL-TK co-
transfected as internal control, and then expressed as percent relative luciferase units (RLU) given by pGL3-HPO(31222/+205). Results are
represented as the meanUS.D. of three independent experiments in triplicate. C: A minimal core promoter activity in the region 322 to +42.
A fragment extending from 354 to +205 was truncated from either the 5P- or the 3P-proximal side (left, open bar). The constructs were trans-
fected into HepG2 cells and luciferase activities were measured (¢lled bar). The ¢re£y luciferase activities were normalized to the Renilla lucifer-
ase activity, and then were presented as percent relative to activity of pGL3-HPO(354/+205). Results are represented as the meanUS.D. of
four independent experiments in duplicate. D: Alignment of Inr-like element between murine TdT core promoter and HPO core promoter. The
Inr-like element and three CTGGAGGC repeat elements, designated Inr, R1, R2 and R3 respectively, are presented in the region from 322 to
+42 of pGL3-HPO(354/+205). The three repeat elements are indicated by lines above the sequence. The Inr-like element of HPO was aligned
to the murine TdT Inr element. The putative transcription start site was denoted +1.
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3.3. A functional initiator and its £anking CTGGAGGC repeats
comprise the core promoter of the HPO gene
To test whether the Inr-like element and the triple repeats in
the HPO promoter region are functional, mutagenesis on the
elements of interest was performed in the context of pGL3-
HPO(354/+205) and the mutants were transiently transfected
into HepG2 cells. Reporter assay data (Fig. 2A) showed that
the transition of A to G at site +1 reduced transcriptional
activity of the promoter to about 11% relative to the activity
of the wild-type promoter. Transversion of TC to GA at
positions 31/32 and TC to AG at +2/+3 also reduced the
promoter activity, but less strongly than the +1 mutation (Fig.
2B). These data clearly indicate that the nucleotides between
32 and +3, and especially A at +1, are critical for e⁄cient
transcription of the HPO promoter in vivo. This is consistent
with the ¢ndings for several other Inr-containing promoters,
in which mutation at 33 to +3 drastically impaired in vivo
transcription [19]. This sequence is also consistent with the
preferred PyPyAþ1NPyPy consensus sequence for a functional
Inr element [20]. The Inr-proximal sequence has been found to
be essential for the transcription of several Inr-containing
genes [18,21]. In contrast to those genes, intriguingly, three
tandem repeats of a CTGGAGGC sequence in the HPO
core promoter were arrayed in the space of 4 bp (Fig. 1D).
To assess the functional importance of the CTGGAGGC se-
quence for the promoter activity, we mutated the TGGA of
each repeat to GTTC in the context of pGL3-HPO(354/+205)
(Fig. 2A). The transcriptional activity of those constructs was
measured by transient transfection in HepG2 cells. Mutation
of R1 and R3 very strongly reduced the activity of HPO
Fig. 2. Reporter assay of the functional initiator and its £anking CTGGAGGC repeat elements. A: The region from 322 to +10, which con-
tains the Inr-like element and triple repeats, was mutated in the context of pGL3-HPO(354/+205). The mutated nucleotides are underlined cor-
responding to the sites of wild-type and marked on the left. B: E¡ect of mutagenesis on Inr elements. The mutants of Inr were transfected into
HepG2 cells and the e¡ect of mutagenesis was represented as percent relative to wild-type pGL3-HPO(354/+205). C: E¡ect of mutagenesis of
three CTGGAGGC tandem repeat elements. Xs indicate mutations introduced at speci¢c sites marked on the left. The mutants of Inr-£anking
element were transfected into HepG2 cells and the e¡ect of mutagenesis was represented as percent relative to wild-type pGL3-HPO(354/
+205). Results are represented as the meanUS.D. of three independent experiments in triplicate.
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relative to wild-type, and mutation of R2 had a lesser e¡ect
(Fig. 2C). A combination of mutated R2, R3 and the muta-
tion of the +1 site from A to G further reduced the promoter
activity to about 8% of wild-type activity (Fig. 2C). These
results suggest that the CTGGAGGC repeats, especially R1
and R3, are important for optimal Inr-dependent transcrip-
tion of the HPO gene.
3.4. Speci¢c nuclear factors bind to the initiator and
CTGGAGGC cis-acting elements
Cis-acting elements are generally bound by trans-acting fac-
tors. We therefore assayed HepG2 and HeLa nuclear extracts
for factors speci¢cally binding to the Inr and CTGGAGGC
repeat element. We performed EMSA using 32P-labeled dou-
ble-stranded oligonucleotides containing the wild-type HPO
Inr and R1 element or corresponding point mutants. For
the Inr oligonucleotides, nuclear extract from HepG2 and
HeLa cells both formed two gel-shifted complexes. Those
complexes could be abolished by unlabeled wild-type Inr
probe, but were competed neither by irrelevant probes corre-
sponding to SP1 or AP1 binding sites, nor by oligonucleotides
mutated at the 32/+2 or +4/+7 sites (Fig. 3A,B). The two
shifted complexes have only a slight di¡erence in electropho-
retic mobility rate, but di¡er considerably in sensitivity to
competition by unlabeled Inr probe. Complex 2 from HeLa
nuclear extract and complex 1 from HepG2 extract could be
abolished by a 100-fold molar excess of cold probe. However,
complex 1 from HeLa extract and complex 2 from HepG2
Fig. 3. Binding of speci¢c nuclear factors to Inr and CTGGAGGC repeat elements. A: 35 fmol 32P-labeled Inr probe was incubated with 5 Wg
HeLa nuclear extract (NE) in the absence (lane 1) or presence (lanes 2^8) of NE. For lanes 3^7, a 100-fold molar excess of the indicated cold
competitor was added as follows: mutated Inr at 32/+2 (lane 3) and +4/+7 (lane 4), SP1 (lane 5), AP1 (lane 6), wild-type Inr (lane 7); for
lane 8, a 500-fold molar excess of wild-type Inr cold probe was added. Arrows 1 and 2 indicate the shifted protein^DNA complexes. B: 35
fmol 32P-labeled Inr probe was incubated with 5 Wg HepG2 NE in the absence (lane 1) or presence (lanes 2^7) of NE. Cold competitors were
added in binding reaction as shown on the left (fold excess in parentheses) before addition of labeled probe. The plus represents addition of
cold competitor and minus represents no addition of competitors. Shifted complexes are indicated by arrows. C: 32P-labeled R1 probe was in-
cubated with 5 Wg HeLa NE in the absence (lane 1) or presence (lanes 2^8) of NE, with addition of competitors as described above. D: 32P-la-
beled R1 probe was incubated with 5 Wg HepG2 NE in the absence (lane 1) or presence (lanes 2^8) of NE, with addition of competitors as de-
scribed above.
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extract could not, indicating that these complexes are stabler.
Similar results were obtained for the CTGGAGGC repeat
element. Two major complexes were formed in both binding
reactions, and they displayed di¡erent sensitivities to compe-
tition by the unlabeled R1 probe (Fig. 3C,D). Complex 2 is
stabler than complex 1 for nuclear extracts from HeLa or
HepG2 cells. Thus, nuclear factors speci¢cally recognize and
bind to the Inr and the CTGGAGGC repeat elements. Fur-
thermore, the similar binding patterns suggest that similar
nuclear factors from HepG2 and HeLa cells may bind to
both the Inr and the repeat elements.
4. Discussion
In this report we describe the identi¢cation and character-
ization of the TATA-less HPO promoter region. Through a
series of sequential deletions from the 5P-end of cloned frag-
ments of the HPO promoter, we demonstrated that a core
promoter is present between 354 and +42 (Fig. 1B,C). Muta-
genesis studies showed that this core promoter consists of a
functional initiator and three CTGGAGGC tandem repeat
elements (Fig. 2B,C). Both the initiator and at least one of
the repeats (R1) were bound by speci¢c nuclear factors (Fig.
3A^D). Our results indicate that Inr and CTGGAGGC ele-
ments potentially comprise a novel type of core promoter that
might maintain constitutive expression of at least one tran-
script of the HPO gene.
4.1. Constitutive and inducible expression of the HPO gene
Expression pro¢les showed that HPO is widely expressed in
all of the tested tissues and cell lines (unpublished data). So
far, it has been demonstrated that HPO/ALR/Erv1 distributes
into several subcellular compartments, including the nucleus
[8], mitochondria intermembrane space [11], cell membrane
[5^7], endoplasmic reticulum [22] and extracellular space
[23]. In addition, it is involved in many fundamental processes
including protein folding [22], mitochondrial maintenance
[24,25], transmembrane signaling cascade [5,7], cellular iron
homeostasis [26], and the regulation of nuclear gene expres-
sion [8,9,27]. Some of those functions may represent constitu-
tive roles of HPO, such as in mitochondrion biogenesis and
protein folding, which are indispensable in all cells. However,
others might re£ect inducible functions such as transcriptional
regulation of nuclear genes and transmembrane signaling cas-
cade, in which HPO could be conditionally induced under
stresses such as partial hepatectomy, hepatitis and hepatic
carcinogenesis. Those versatile functions need the HPO gene
to be expressed both in a constitutive and in an inducible
fashion. Through reporter assays of HPO 5P-end sequential
truncations, here we found that the transcription of the HPO
gene is initiated through an Inr-containing core promoter.
Moreover, the data obtained from serial deletions of the pro-
moter region showed that the promoter region of HPO mainly
has more the characteristics of a housekeeping gene. Consis-
tent with our ¢ndings, the promoters of human housekeeping
genes, oncogenes, growth factors, and transcription factors
are often TATA-less [28]. Our ¢ndings partly explain the
mechanisms in which one transcript of the HPO gene is con-
stitutively regulated. Some studies showed that expression of
the HPO gene is higher under certain circumstances such as
partial hepatectomy [29] or acute liver diseases [10] than
in normal states. It is possible that some transcripts of HPO
can be conditionally induced under stress. Further e¡orts are
needed to elucidate the regulatory mechanism of inducible
expression of HPO.
4.2. Inr together with its £anking CTGGAGGC element
comprises a subset of Inr-dependent core promoters
Studies on eukaryotic promoters have identi¢ed several
kinds of core promoter elements, which are characteristic
DNA sequences required for promoter function [30]. The
TATA box is an A/T-rich sequence located V25^30 nucleo-
tides upstream of the transcriptional start site. It contains a
consensus sequence, TATA(A/T)A(A/T), which is recognized
by the TATA binding protein subunit of TFIID, which nucle-
ates the formation of a pre-initiation complex [31]. The down-
stream promoter element (DPE), which is located 28^34 nu-
cleotides downstream of the transcription start site in many
Drosophila TATA-less promoters [30,32], has a consensus se-
quence (A/G)G(A/T)CGTG. Two of the DPE-acting factors,
TFIID and NC2, may work synergistically through the DPE
[33]. An upstream core promoter element, (G/C)(G/C)(G/
A)CGCC, is recognized by TFIIB. This TFIIB recognition
element (BRE) is located immediately upstream of the
TATA box of some promoters and increases the a⁄nity of
TFIIB for the promoter [34]. The initiator is another con-
served core promoter element, which contains a pyrimidine
(Y)-rich core sequence YYAþ1N(T/A)YY encompassing the
transcriptional start site [19]. It is su⁄cient to direct accurate
transcription initiation either alone or in conjunction with a
TATA box or other core promoter element [31,35]. Among
the binding factors of Inr, TAFII250 is a major candidate.
TAFII250, together with TAFII150, is widely used in both
TATA-box-containing and TATA-less core promoters and
mediates binding of TFIID to the Inr [36,37]. Several other
factors including RNA polymerase II [38], TFII-I [39], USF
[40] and YY1 [41] have been implicated in Inr function. How-
ever, they are restricted to a small subset of Inr elements [19].
These four kinds of core promoter elements, either alone or
combined with others, form distinct classes of core promoters
corresponding to di¡erent sets of genes. The various types of
core promoter combinations, including TATA alone, TATA
with DPE, TATA with Inr, TATA with BRE and Inr alone or
Inr with DPE, are then recognized by distinct combinations of
general transcription factors, especially distinct set of TAFs
[30,42]. Now we speculate that Inr with a CTGGAGGC ele-
ment ^ an Inr-dependent £anking element (IFE) ^ might com-
prise a novel type of core promoter to direct expression of a
subset of genes including HPO.
Fig. 4. The IFE can lie upstream or downstream of the initiator ele-
ment. Inr and IFE are present in many TATA-less genes, named on
the left. The transcription start site within the initiator, usually ad-
enine, is underlined and aligned. The IFE is in bold type. CFI,
complement factor I; PBGD, human porphobilinogen deaminase;
XDH, xanthine dehydrogenase; C1INH, C1 inhibitor.
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The core promoter of HPO is TATA-less and Inr-contain-
ing. Sequence examination near Inr showed that the proximal
region of Inr is G/C-rich and does not contain the consensus
sequence of TATA, DPE or BRE elements. Interestingly,
three tandem repeats of CTGGAGGC were found surround-
ing the Inr, and all of them make a great contribution to Inr-
dependent transcription. More interestingly, these repeating
element, lying either upstream or downstream of Inr, appear
in many other Inr-containing genes, such as complementary
factor I [21], TdT [18], human porphobilinogen deaminase
[43], xanthine dehydrogenase [44], C1 inhibitor [45], singled
[42], etc. (shown in Fig. 4). They have a consensus sequence
CTGGNNN(N)C. Based on these results, we could postulate
that the CTGGNNN(N)C sequence, as an IFE, together with
Inr consists of one type of core promoter. This type of core
promoter, denoted Inrþ-IFEþ, drives transcription of a subset
of genes. It is clear that speci¢c nuclear factors bind to the Inr
and IFE elements. Nevertheless, further study is needed to
identify those nuclear proteins, which would be helpful to
understand how IFE combines with Inr to facilitate the as-
sembly of the basic transcription machinery on the core pro-
moter.
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